Assertion: fibrosis's risk | /r/CapableOf | outweigh benefit
Facets:
value: with gadodiamide
type: OTHER
value: with both gadopentetic acid
type: OTHER
Source sentences:
text: With both Gadopentetic acid (gadopentetate dimegulumine (Magnevist)) and Gadodiamide (Omniscan) the risk was considered to outweigh the benefits and, as a result, the EMA recommended the licence for intravenous gadopentetic acid and Gadodiamide be suspended.